Associate General Counsel

Overview:

The Associate General Counsel will assist the General Counsel in overseeing legal matters for the Company, including with respect to securities, corporate transactions, corporate secretary duties, processes and procedures, HR matters, agreements (including manufacturing and clinical agreements), and compliance. This position will be the key interface with license partners with regard to licenses and collaborations.  The position reports to the General Counsel.

Company:

SELLAS is a publicly traded, late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications.  SELLAS’ lead product candidate, galinpepimut-S (GPS), licensed from Memorial Sloan-Kettering Cancer Center (MSKCC), is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen.  The WT1 antigen is one of the most widely expressed cancer antigens and is ranked by the National Cancer Institute (NCI) as the top priority among cancer antigens for immunotherapy.  Traditional approaches have not yet been proven to successfully address the WT1 protein, as WT1 is not druggable with small molecules and is intracellular and inaccessible to antibodies.

Compensation:

Competitive and commensurate with experience, consisting of base, bonus and equity.

Experience:

• College and law degrees from accredited schools.
• 5+ years of attorney experience (law firm, in-house or combination).
• Current member in good standing of the NY bar.
• Experience in corporate transactions and agreement drafting and negotiation required.
• Experience with securities matters required.
• Experience with and understanding of pharmaceutical and biotechnology industries and issues required.

Location: New York, NY.